Lyra Therapeutics reports disappointing results for LYR-210 in Phase 3 chronic rhinosinusitis trial

Lyra Therapeutics reports disappointing results for LYR-210 in Phase 3 chronic rhinosinusitis trial

Lyra Therapeutics, Inc. (Nasdaq: LYRA), dedicated to advancing treatments for chronic rhinosinusitis (CRS), announced that its Phase 3 ENLIGHTEN 1 trial evaluating LYR-210 did not meet its primary endpoint. The trial aimed to demonstrate a statistically significant improvement over a sham control in treating CRS symptoms, but the results at 24 weeks fell short of […]

AstraZeneca Pharma India, Mankind Pharma announce distribution partnership for asthma medication Symbicort

AstraZeneca Pharma India, Mankind Pharma announce distribution partnership for asthma medication Symbicort

AstraZeneca Pharma India Limited (AstraZeneca India) and Mankind Pharma Limited have embarked on a strategic collaboration for the exclusive distribution of AstraZeneca’s asthma medication, Symbicort (budesonide and formoterol fumarate dihydrate combination). This partnership aims to leverage Mankind Pharma’s expansive distribution network to enhance the accessibility and effectiveness of asthma treatment across India, a country contributing […]

Indoco Remedies’ Warren Remedies commences commercial production in Aurangabad

Indoco Remedies’ Warren Remedies commences commercial production in Aurangabad

Warren Remedies Private Limited, a wholly-owned subsidiary of Indoco Remedies Limited, has officially started its commercial operations on March 1, 2024. The new Greenfield manufacturing facility, located in Aurangabad, Maharashtra, is set to produce a range of oral care products. This strategic move aims to bolster the company’s manufacturing capabilities and meet the growing demand […]